Key facts
- Notable investors include Plug and Play Tech Center, In5, StartAD.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Pioneera Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Pioneera Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pioneera Biosciences
Developer of advanced therapeutic medicinal products designed to increase access to cell and gene therapies. The company offers biotechnological products focused on therapeutic applications, including the development and manufacturing of advanced therapies for rare and complex diseases, enabling healthcare providers and patients in global markets to access innovative treatment options and improve health outcomes.
- Sector
- Healthcare
- HQ
- Lithuania
- Founded
- 2024
- Website
- pioneerabio.com/
- Ownership
- Privately Held (backing)
Pioneera Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pioneera Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pioneera Biosciences in its N-PORT filings yet. We sweep new filings monthly.